These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 29439446)
1. The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases. Rubattu S; Sciarretta S; Marchitti S; Bianchi F; Forte M; Volpe M Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439446 [TBL] [Abstract][Full Text] [Related]
2. C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling. Sciarretta S; Marchitti S; Bianchi F; Moyes A; Barbato E; Di Castro S; Stanzione R; Cotugno M; Castello L; Calvieri C; Eberini I; Sadoshima J; Hobbs AJ; Volpe M; Rubattu S Circ Res; 2013 May; 112(10):1355-64. PubMed ID: 23529183 [TBL] [Abstract][Full Text] [Related]
3. C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro. Stanzione R; Sciarretta S; Marchitti S; Bianchi F; Di Castro S; Scarpino S; Cotugno M; Frati G; Volpe M; Rubattu S Cell Death Dis; 2015 Dec; 6(12):e2033. PubMed ID: 26720342 [TBL] [Abstract][Full Text] [Related]
4. C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP. Carnevale R; Pignatelli P; Frati G; Nocella C; Stanzione R; Pastori D; Marchitti S; Valenti V; Santulli M; Barbato E; Strisciuglio T; Schirone L; Vecchione C; Violi F; Volpe M; Rubattu S; Sciarretta S Sci Rep; 2017 Jun; 7(1):3797. PubMed ID: 28630469 [TBL] [Abstract][Full Text] [Related]
5. The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells. Rubattu S; Marchitti S; Bianchi F; Di Castro S; Stanzione R; Cotugno M; Bozzao C; Sciarretta S; Volpe M PLoS One; 2014; 9(11):e113108. PubMed ID: 25401746 [TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro. Scarpino S; Marchitti S; Stanzione R; Evangelista A; Di Castro S; Savoia C; Quarta G; Sciarretta S; Ruco L; Volpe M; Rubattu S J Hypertens; 2009 Sep; 27(9):1804-13. PubMed ID: 19702001 [TBL] [Abstract][Full Text] [Related]
7. T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients. Rubattu S; De Giusti M; Farcomeni A; Abbolito S; Comito F; Cangianiello S; Greco ES; Dito E; Pagliaro B; Cotugno M; Stanzione R; Marchitti S; Bianchi F; Di Castro S; Battistoni A; Burocchi S; Caprinozzi M; Pierelli G; Sciarretta S; Volpe M J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):601-7. PubMed ID: 25252038 [TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Cannone V; Huntley BK; Olson TM; Heublein DM; Scott CG; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC Hypertension; 2013 Nov; 62(5):860-5. PubMed ID: 24041948 [TBL] [Abstract][Full Text] [Related]
9. T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort. Pastori D; Carnevale R; Stanzione R; Nocella C; Cotugno M; Marchitti S; Bianchi F; Forte M; Valenti V; Biondi-Zoccai G; Schiavon S; Vecchio D; Versaci F; Frati G; Violi F; Volpe M; Pignatelli P; Rubattu S; Sciarretta S Int J Cardiol; 2021 Jan; 322():245-249. PubMed ID: 32861716 [TBL] [Abstract][Full Text] [Related]
10. T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients. Strisciuglio T; Barbato E; De Biase C; Di Gioia G; Cotugno M; Stanzione R; Trimarco B; Sciarretta S; Volpe M; Wijns W; Delrue L; Rubattu S J Cardiovasc Transl Res; 2018 Feb; 11(1):36-41. PubMed ID: 29209941 [TBL] [Abstract][Full Text] [Related]
12. Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. Barbato E; Bartunek J; Mangiacapra F; Sciarretta S; Stanzione R; Delrue L; Cotugno M; Marchitti S; Iaccarino G; Sirico G; Di Castro S; Evangelista A; Lambrechts D; Sinnaeve P; De Bruyne B; Van De Werf F; Janssens S; Fox KA; Wijns W; Volpe M; Rubattu S J Am Coll Cardiol; 2012 May; 59(20):1763-70. PubMed ID: 22575314 [TBL] [Abstract][Full Text] [Related]
13. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975 [TBL] [Abstract][Full Text] [Related]
14. Association between the atrial natriuretic peptide rs5065 gene polymorphism and the presence and severity of coronary artery disease in an Iranian population. Ziaee S; Kalayinia S; Boroumand MA; Pourgholi L; Cheraghi S; Anvari MS; Sheikhvatan M Coron Artery Dis; 2014 May; 25(3):242-6. PubMed ID: 24487939 [TBL] [Abstract][Full Text] [Related]
15. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease. Cannone V; Cabassi A; Volpi R; Burnett JC; Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269783 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Rubattu S; Stanzione R; Di Angelantonio E; Zanda B; Evangelista A; Tarasi D; Gigante B; Pirisi A; Brunetti E; Volpe M Stroke; 2004 Apr; 35(4):814-8. PubMed ID: 15017020 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Song W; Wang H; Wu Q Gene; 2015 Sep; 569(1):1-6. PubMed ID: 26074089 [TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide T2238C gene polymorphism and the risk of cardiovascular diseases: A meta‑analysis. Wang J; Yang Y; Zheng M; Zhang L; Wulasihan M Biomed Rep; 2024 Mar; 20(3):41. PubMed ID: 38357235 [TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease. Hassan A; Ali N; Dong Y; Carter ND; Markus HS Neurology; 2001 Nov; 57(9):1726-8. PubMed ID: 11706124 [TBL] [Abstract][Full Text] [Related]
20. Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization. Nagai-Okatani C; Kangawa K; Minamino N J Pept Sci; 2017 Jul; 23(7-8):486-495. PubMed ID: 28120499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]